{"nct_id":"NCT02986854","title":"Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination","status":"COMPLETED","status_verified_date":"2019-11","start_date":"2016-12-08","start_date_type":"ACTUAL","primary_completion_date":"2017-07-17","primary_completion_date_type":"ACTUAL","completion_date":"2017-12-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}